Ken Herrmann sold $119K of AKTS stock

Ken Herrmann, Dir of Aktis Oncology, Inc. (AKTS), sold 4,856 shares of AKTS stock worth $119K, per an SEC Form 4 filed Jul 22, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 20, 2026, 2 days before it was made public.

AKTS has moved -28.9% since the trade date, from $23.96 to $17.04 (Nov 11, 2026 close).